Peptides for Pigmentation Research

Pigmentation research investigates peptides affecting melanocyte function and melanin synthesis. Melanotan II is studied as an α-MSH analogue that stimulates melanin production via melanocortin receptors. KPV is examined for anti-inflammatory effects on hyperpigmentation. GHK-cu is investigated for skin tone modulation and overall skin quality. Research focuses on melanin upregulation, hyperpigmentation reversal, and skin tone uniformity.

Melanotan II research shows potent melanin production in human studies, with documented darkening of skin and increased pigmentation in fair-skinned populations. KPV demonstrates anti-inflammatory activity in cell cultures relevant to inflammatory hyperpigmentation. GHK-cu shows growth factor upregulation and general skin improvement, though pigmentation-specific data are limited.

Melanotan II human safety data are sparse; long-term effects on melanoma risk are uncertain and debated. KPV pigmentation research is primarily in vitro; clinical human data are minimal. Comparative effectiveness for specific pigmentation disorders (melasma, post-inflammatory hyperpigmentation) is poorly characterised. Long-term cosmetic outcomes are underdocumented.

Melanin-modulating peptides are not ARTG-approved for cosmetic use. Melanotan II in particular carries significant regulatory scrutiny due to limited safety data. Research-grade supply for institutional use is legal; personal cosmetic pigmentation use is not TGA-authorised. Medical practitioners cannot prescribe these for cosmetic pigmentation enhancement.